Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls Norepinephrine Bitartrate in 5% Dextrose Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.
Products
  • Norepinephrine Bitartrate in 5% Dextrose Injection
Where it was sold

Nationwide in the USA

Nationwide

Units affected
13,000 bags
About this recall
Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20